News

This article delves into 5 critical areas that dermatologists should focus on for a comprehensive 2024 report card.

Researchers from Pyeongchon, Korea, argue that evidence points to the need for a change in the terminology of "freckling," according to a poster from Maui Derm Hawaii.

A poster presented at Maui Derm Hawaii delved into the efficacy and safety of trifarotene 50µg/g cream in acne vulgaris and PIH.

In a recent Dermatology Times Case-Based Roundtable Meeting, Tina Bhutani, MD, MAS, shared intriguing cases and insights about atopic dermatitis treatment challenges faced by patients with different lifestyles and hobbies.

Investigators explained how the trial is structured to inhibit facial sebum production and inflammation among nearly 500 study participants.

Online patient recruitment methods were effective in a proof-of-concept trial involving patients with low-grade AK.

Click here to answer this week's poll.

Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.

Almost 90% of white men and 85% of white women who received a diagnosis of melanoma in 2018 were likely overdiagnosed, according to a new study.

Approximately half of patients presenting to dermatology clinics in Beirut reported the use of sunscreen.

The finalized acquisition comes 5 months after Timber Pharmaceuticals filed for chapter 11 bankruptcy.

Among dermatologists specializing in pediatric alopecia areata, a survey found that class 1 and 2 topical corticosteroids are the preferred first-line therapy.

A study explored the prioritization habits of both patients with atopic dermatitis and their caregivers when it comes to treatment.

Subjects who received Sculptra treatments reported improvement in skin radiance and firmness.

DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.

A recent review evaluated the role of camouflage and concealment techniques and their role in improving the well-being of Black women with hair loss.

Researchers also found that explainable AI methods, also known as XAI, further contributed to the confidence and accuracy associated with AI assistance.

Zoryve was approved for the treatment of seborrheic dermatitis in patients ages 9 years and older in December.

In a recent study, prenatal opioid exposure was also linked to increased odds of infections and asthma, but not with allergies, anaphylaxis, orautoimmune conditions.

The VISIBLE clinical program will create a longitudinal collection of more than 20,000 clinical images across all skin tones.

Keep up with the latest headlines in dermatology from the past week, including wildfire smoke associated with a spike in dermatology visits, microbiome research findings tied to skin aging, and more.

ICYMI, this week we had news about Winter Clinical Hawaii data, FDA updates to dupilumab's label to include hand and foot AD involvement, the phase 1 trial of EVO756 for adults with chronic spontaneous urticaria, and more.

The 40-GEP test could help patients with skin cancer avoid adjuvant radiation therapy while simultaneously saving millions in health care costs.

The high-concentration and citrate-free biosimilar was first available in a single 40 mg dose.

Among the many sessions to be held at the Maui Derm Hawaii 2024 conference on Maui, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Click here to answer our poll.

A recent study explored the risk of skin cancer faced by patients undergoing phototherapy without psoralens.

The hand-held DermaSensor uses an AI algorithm to noninvasively evaluate suspicious skin lesions for cancer.

In this week’s Pointers With Portela, the 208SkinDoc compares Accutane to 5 Aminolevulinic acid with red light therapy.

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.